LEAH GUMUCIO: Open Payments
NPI 1992074496 · WATKINSVILLE, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$493 in 28 payments from 11 companies in 2025. Trend: 2023 $582 · 2024 $257 · 2025 $493
Food & beverage: $493
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 4 | $97 |
| Sumitomo Pharma America, Inc. | 5 | $97 |
| Biogen, Inc. | 4 | $95 |
| MAYNE PHARMA COMMERCIAL LLC | 7 | $58 |
| Amgen Inc. | 2 | $32 |
| Dexcom, Inc. | 1 | $26 |
| MILLICENT US INC | 1 | $25 |
| Becton, Dickinson and Company | 1 | $18 |
| Exeltis, USA Inc. | 1 | $16 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Veozah, MYFEMBREE, ZURZUVAE, EVENITY, Dexcom G6 Transmitter, FEMRING, ARISTA, SLYND.
Industry payments across GA — which companies pay providers there.
